Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 9, Y-linked pseudogene 33 (USP9YP33) is a member of the family of pseudogenes related to the functional USP9Y gene, which encodes a ubiquitin-specific protease essential for male germ cell development[1][4]. USP9YP33 itself is a genomic sequence that resembles USP9Y but does not produce a functional protein product. As such, it has no known biological activity or role in disease and is not considered a therapeutic target. Pseudogenes like USP9YP33 can arise via duplication or retrotransposition and may occasionally play regulatory roles, but these functions remain uncharacterized for USP9YP33 specifically[2][6]. Most biomedical resources only annotate this as a pseudogene with no clinical significance or actionable properties.
Null (no mechanism is known or applicable, as no active protein is encoded)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 9, Y-linked pseudogene 33 (USP9YP33).